EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA AND HIGH BASELINE BLOOD EOSINOPHIL COUNTS

被引：0
|
作者：
Jain, N.
Llanos-Ackert, J.
Ambrose, C.
Cook, B.
Ponnarambil, S.
Martin, N.
Webb, L.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2022年 / 129卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P086
引用
收藏
页码：S36 / S37
页数：2
相关论文
共 50 条
  • [1] Efficacy of tezepelumab in patients with severe, uncontrolled asthma and low blood eosinophil counts not receiving maintenance oral corticosteroids
    Menzies-Gow, A.
    Cook, B.
    Colice, G.
    Hellqvist, A.
    Llanos-Ackert, J. P.
    Ambrose, C. S.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [2] Association of Baseline Blood Eosinophil Counts and Serum IgE Concentrations on Exacerbations and Benralizumab Efficacy for Patients with Severe, Uncontrolled Asthma
    Gil, E. G.
    Jackson, D. J.
    Humbert, M.
    Hirsch, I
    Newbold, P.
    [J]. PNEUMOLOGIE, 2020, 74 : S26 - S26
  • [3] ASSOCIATION OF BASELINE BLOOD EOSINOPHIL COUNTS AND SERUM IGE CONCENTRATIONS ON EXACERBATIONS AND BENRALIZUMAB EFFICACY FOR PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA
    Jackson, D. J.
    Humbert, M.
    Hirsch, I.
    Newbold, P.
    Gil, E. Garcia
    [J]. THORAX, 2019, 74 : A34 - A35
  • [4] GREATER EFFICACY OF MEPOLIZUMAB IN SEVERE EOSINOPHILIC ASTHMA WITH HIGH BASELINE BLOOD EOSINOPHIL COUNTS
    Silver, J.
    Llanos, J.
    Mayer, B.
    Prazma, C.
    Albers, F.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S37 - S38
  • [5] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA GROUPED BY BASELINE BMI IN THE NAVIGATOR STUDY
    Chupp, Geoffrey
    Menzies-Gow, Andrew
    Ambrose, Christopher
    Cook, William
    Kmita, Kamil
    Lindsley, Andrew
    Llanos-Ackert, Jean-Pierre
    Colice, Gene
    Lugogo, Njira
    [J]. CHEST, 2021, 160 (04) : 37A - 40A
  • [6] Efficacy of tezepelumab in patients with severe, uncontrolled asthma, according to baseline blood eosinophil count and allergic status: results from the phase 3 NAVIGATOR study
    Menzies-Gow, A.
    Corren, J.
    Cook, B.
    Kmita, K.
    Llanos-Ackert, J.
    Colice, G.
    Ambrose, C. S.
    [J]. ALLERGY, 2021, 76 : 21 - 22
  • [7] Effect of tezepelumab on seasonal exacerbations in patients with severe, uncontrolled asthma grouped by blood eosinophil count
    Corren, J.
    Menzies-Gow, A.
    Ambrose, C. S.
    Colice, G.
    Roseti, S. L.
    Hellqvist, A.
    Kmita, K.
    Lindsley, A. W.
    Cook, B.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [8] Effect of Tezepelumab on Airway Hyperresponsiveness by Baseline Blood Eosinophil Count in Patients With Severe, Uncontrolled Asthma in the Phase 2 CASCADE Study
    Brightling, C. E.
    O'Byrne, P. M.
    Porsbjerg, C.
    Boulet, L.
    Martin, N.
    Molfino, N. A.
    Megally, A.
    Griffiths, J. M.
    Clarke, D.
    Martin, N.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [9] Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma and Fungal Sensitization
    Corren, Jonathan
    Mathur, Sameer K.
    Carr, Tara F.
    Wardlaw, Andrew J.
    Caminati, Marco
    Martin, Nicole
    Ponnarambil, Sandhia
    Lindsley, Andrew W.
    Spahn, Joseph D.
    Martin, Neil
    Geffen, David
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB97 - AB97
  • [10] Efficacy of tezepelumab in adolescents with severe, uncontrolled asthma
    Israel, Elliot
    Menzies-Gow, Andrew
    Chupp, Geoffrey
    Ambrose, Chris
    Cook, Bill
    Hunter, Gillian
    Llanos-Ackert, Jean-Pierre
    Downie, John
    Colice, Gene
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
12345